Successful treatment of non-segmental vitiligo: Systemic therapy with sex hormone-thyroid powder mixture

Hormone Research

Volumn 54, Issue 5-6, 2000, Pages 316-317

  Nagai, Ko ^a,b   Ichimiya, Makoto ^a   Yokoyama, Kazuo ^a   Hamamoto, Yoshiaki ^a   Muto, Masahiko ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Melanocyte stimulating hormone ( MSH); Vitiligo

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; ESTROGEN DERIVATIVE; METHARMON F; MONOCLONAL ANTIBODY; STEROID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPIGMENTATION; DRUG FORMULATION; DRUG MECHANISM; DRUG SCREENING; FEMALE; HORMONE RELEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTE; MELANOGENESIS; POWDER; PRIORITY JOURNAL; SKIN BIOPSY; TOPICAL TREATMENT; VITILIGO;

ADULT; AGED; ALPHA-MSH; ANDROSTENEDIOL; ANDROSTENEDIONE; DRUG COMBINATIONS; DRUG RESISTANCE; ESTRONE; FEMALE; HUMANS; MALE; MELANOCYTES; MIDDLE AGED; PREGNENOLONE; SEX CHARACTERISTICS; SKIN PIGMENTATION; TESTOSTERONE; THYROID GLAND, DESICCATED; TIME FACTORS; VITILIGO;

EID: 0034583410     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053279     Document Type: Conference Paper

References (6)

1. Immune mechanisms in vitiligo
2. Successful treatment of vitiligo with a sex steroid-thyroid hormone mixture
3. Human melanocyte as a target tissue hormone: In vitro studies with 1α-25 dihydroxyvitamine D3, melanocyte stimulationg hormone and estradiol
4. Sensitivity of human melanoma cells to oestrogens, tamoxifen and quercetin: Is there any relationship with type I and type II oestrogen binding site expression?
5. On the potential role of proopiomelanocortin in skin physiology and pathology
6. Alpha-melanocyte-stimulating hormone immunoreactivity in melanoma cells